Cargando…
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
The complement system has moved into the focus of drug development efforts in the last decade, since its inappropriate or uncontrolled activation has been recognized in many diseases. Some of them are primarily complement-mediated rare diseases, such as paroxysmal nocturnal hemoglobinuria, C3 glomer...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092519/ https://www.ncbi.nlm.nih.gov/pubmed/30135690 http://dx.doi.org/10.3389/fimmu.2018.01851 |